Removal of thioridazine from primary care formulary will result in prescribing vacuumBMJ 2001; 323 doi: http://dx.doi.org/10.1136/bmj.323.7314.695 (Published 22 September 2001) Cite this as: BMJ 2001;323:695
- Nat Wright, general practice consultant in substance misuse and homelessness ([email protected])
- No Fixed Abode Health Centre for Homeless People, Leeds LS9 8AA
EDITOR—Recently the Committee on the Safety of Medicines recommended that general practitioners should not prescribe thioridazine.1 It recommended that prescribing should be limited to second line treatment in schizophrenia and that prescription should be initiated only by a consultant psychiatrist. The reason was that the drug was thought to be a cause of very rare cardiac deaths by widening the QT interval in an electrocardiogram, leading to a greater risk of developing arrhythmias.
The evidence base to substantiate this decision is not, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial